FX MASTER LIMITED

Company number 05248673 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

1. Financial Health Score: B-

Explanation: The patient exhibits robust short-term immunity (liquidity) and has just undergone a major growth operation, but is carrying a significant new burden of long-term debt. The overall financial weight (net assets) has been on a worrying decline over the last few years, though the latest period shows a tentative recovery. The lack of detailed profit and loss transparency (due to Micro-entity filing status) means we are diagnosing heavily from the balance sheet alone, but the vital signs suggest a business that is stable but under the strain of a recent, substantial financial restructuring.

2. Key Vital Signs

  • Blood Pressure (Liquidity): Healthy and strong. Current assets stand at £167,255 against current liabilities of just £503. This gives a current ratio of over 330:1, meaning the company has more than enough liquid resources to meet its immediate obligations. There is absolutely no risk of a short-term cash flow hemorrhage.
  • Cholesterol (Long-term Debt): Elevated and requiring monitoring. In 2023, long-term creditors were non-existent. By 2024, the company has taken on £380,000 in creditors falling due after more than one year. This is a massive structural shift that will require long-term servicing.
  • Muscle Mass (Fixed Assets): Significant growth. Fixed assets ballooned from £5,200 in 2023 to £301,633 in 2024. Combined with the new long-term debt, this strongly suggests the company has taken out a long-term loan to finance a major asset purchase (likely an investment property, given the company's history as "Brazil Properties Limited").
  • Weight (Net Assets): Stabilizing after a period of loss. Net assets grew from £76,078 in 2023 to £88,385 in 2024. However, looking at the wider history, the company's net assets peaked at £222,773 in 2020 before steadily declining. The recent uptick is a positive sign of recovery, but the business is still leaner than it was four years ago.

3. Diagnosis

The patient has undergone major "surgery" in the 2024 financial year. The sudden appearance of £380,000 in long-term debt, matched by a £296,000 increase in fixed assets, indicates a leveraged acquisition—likely a property or long-term investment. Given the company's previous name ("Brazil Properties Limited") and its SIC code (Activities auxiliary to financial intermediation), this aligns with a business model focused on asset holding and financial investment.

While the asset base has expanded significantly, the company's overall equity has only grown by roughly £12,300. This implies that the new asset is almost entirely debt-financed, with very little fresh equity injected.

The historical data reveals a prior "illness": the net assets halved between 2020 and 2023 (dropping from £222k to £76k). Because micro-entity accounts hide the profit and loss statement, we cannot see if this was due to operational losses, asset write-downs, or dividend extraction. However, the bleeding appears to have stopped, and the patient is currently in a stable condition with a modest £12k improvement in overall net worth.

4. Recommendations

  • Cardiovascular Exercise (Debt Servicing Plan): With £380,000 in long-term debt now on the books, the business must ensure it has the recurring "blood flow" (revenue/income) to service the interest and capital repayments. Forecast cash flows should be strictly monitored to ensure the new debt does not become a toxic burden.
  • Monitor the New Asset (Post-Op Check-up): The £301k in fixed assets must generate a sufficient return to justify the cost of the debt. Management should set clear milestones for the return on investment of this newly acquired asset to ensure it is pulling its weight.
  • Protect the Immune System (Maintain Liquidity): The current cash position is healthy, but as long-term debt begins to mature, portions of it will shift to current liabilities. The directors must ensure that current assets are not eroded too quickly, maintaining a buffer to prevent future short-term distress.
  • Review Remuneration Strategy: Given the historical drop in net assets from 2020 to 2023, directors should exercise caution regarding dividend extraction. Retaining profits to rebuild the overall equity base will provide a stronger safety net against the new leverage.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 29 July 2026